Stay updated on Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.

Latest updates to the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page
- Check5 days agoChange DetectedThe page now indicates recruitment is closed ('No longer looking for participants'), which directly affects the ability to join the study. New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the revision version was bumped to v3.6.0.SummaryDifference0.2%

- Check12 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating an internal update to the page version. No study information or user-facing content were changed.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedRevision from v3.5.3 to v3.5.4 indicates a small update to the page or site metadata. It does not modify the study content or outcomes.SummaryDifference0.0%

- Check48 days agoChange DetectedThe non-diacritic Malmo, Sweden, SE-205 02 entry was removed. The diacritic-correct Malmö, Sweden, SE-205 02 entry was added to the location list.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now shows a newer ClinicalTrials.gov revision/build number (“v3.5.3”), replacing the previous (“v3.5.2”). This represents a backend/UI version bump rather than a change to the study details.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.